MFG
ABBV icon

Menard Financial Group’s AbbVie ABBV Stock Holding History

Menard Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
5,140
+54
+1% +$11.6K 0.7% 33
2026
Q1 		$1.11M Sell
5,086
-12
-0.2% -$2.66K 0.77% 30
2025
Q4 		$1.16M Sell
5,098
-32
-0.6% -$7.29K 0.8% 30
2025
Q3 		$1.19M Sell
5,130
-2,819
-35% -$574K 0.8% 33
2025
Q2 		$1.48M Buy
7,949
+341
+4% +$63.4K 0.88% 24
2025
Q1 		$1.42M Buy
7,608
+822
+12% +$160K 0.93% 26
2024
Q4 		$1.21M Buy
6,786
+518
+8% +$95.2K 0.72% 29
2024
Q3 		$1.24M Sell
6,268
-186
-3% -$34.7K 0.82% 27
2024
Q2 		$1.11M Buy
6,454
+1,724
+36% +$286K 0.79% 26
2024
Q1 		$861K Buy
4,730
+2,885
+156% +$497K 0.72% 31
2023
Q4 		$286K Buy
1,845
+137
+8% +$20K 0.36% 60
2023
Q3 		$255K Sell
1,708
-302
-15% -$44.3K 0.37% 63
2023
Q2 		$271K Buy
2,010
+389
+24% +$57K 0.56% 45
2023
Q1 		$258K Hold
1,621
– – 0.6% 46
2022
Q4 		$262K Hold
1,621
– – 0.62% 48
2022
Q3 		$218K Sell
1,621
-45
-3% -$6.46K 0.39% 74
2022
Q2 		$255K Sell
1,666
-655
-28% -$100K 0.42% 69
2022
Q1 		$376K Sell
2,321
-23
-1% -$3.34K 0.37% 87
2021
Q4 		$317K Sell
2,344
-274
-10% -$32.4K 0.26% 107
2021
Q3 		$282K Sell
2,618
-14
-0.5% -$1.6K 0.25% 118
2021
Q2 		$296K Buy
2,632
+96
+4% +$10.8K 0.28% 106
2021
Q1 		$274K Buy
2,536
+47
+2% +$5.03K 0.29% 110
2020
Q4 		$267K Buy
+2,489
New +$239K 0.29% 111
2020
Q3 		– Sell
-2,331
Closed -$229K – 139
2020
Q2 		$229K Buy
+2,331
New +$205K 0.29% 93
2020
Q1 		– Sell
-3,763
Closed -$333K – 22
2019
Q4 		$333K Buy
+3,763
New +$312K 0.32% 100

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Menard Financial Group's ABBV Position: Q2 2026 in Review

Menard Financial Group increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $11.6K and bringing the position to 5,140 shares worth $1.29M. The position accounts for 0.7% of the portfolio, ranked #33.

Menard Financial Group first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.48M in Q2 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Menard Financial Group held 5,140 shares of AbbVie worth $1.29M as of Q2 2026.
  • Menard Financial Group bought 54 AbbVie shares in Q2 2026, an estimated $11.6K.
  • AbbVie made up 0.7% of Menard Financial Group's portfolio in Q2 2026, its #33 holding.
  • Menard Financial Group first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
  • Menard Financial Group's AbbVie position peaked at $1.48M in Q2 2025.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Menard Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.